Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-038910

WEST PHARMACEUTICAL SERVICES INC · WST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Sep 6, 2016
Accepted (ET)
Sep 7, 2016 · 9:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 6, 2016S14,581$83.28D13,513D
Common Stockholding———251IBy Savings Plan
Common Stockholding———1,140INon-Qualified Deferred Compensation Plan

Table II — derivative securities

No Table II lines on this filing.